Abiomed Inc.

This committee provides critical analysis and revenue estimates for all tax legislation, directly influencing corporate tax structures, capital investment credits, and the overall tax burden on companies like Abiomed.

This powerful committee controls taxation, trade, and entitlement spending, including Medicare. Its decisions on corporate tax policy, trade tariffs, and particularly Medicare pricing and reimbursement rates for medical devices, directly impact Abiomed's profitability and market access.

This committee allocates specific federal spending, including for healthcare programs (e.g., Medicare, NIH, VA). Its decisions directly determine the funding available for medical research, procurement of medical devices, and reimbursement, profoundly affecting Abiomed's market.

This committee directly regulates the FDA, which is the primary approval body for Abiomed's medical devices. Its oversight of the NIH also influences medical research funding, directly impacting the company's R&D environment and product pipeline.

This committee oversees intellectual property law (patents), which is crucial for a medical device company like Abiomed with numerous patents. It also handles antitrust issues, which could affect M&A strategies or market competition.

This committee oversees the Department of Veterans Affairs, a significant provider of healthcare services. Its funding and policy decisions directly impact government healthcare contractors and medical device manufacturers like Abiomed, potentially affecting sales to VA hospitals.